1. Vascular Endothelial Growth Factor and Activin-A Serum Levels Following Allogeneic Hematopoietic Stem Cell Transplantation 
David Nachbaur, Petra Schumacher, Jutta Auberger, Johannes Clausen, Brigitte Kircher 
Biology of Blood and Marrow Transplantation 
Volume 13, Issue 8, Pages (August 2007)
DOI: /j.bbmt
Copyright © 2007 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
Mean VEGF and activin-A serum levels ± SE following allogeneic hematopoietic SCT.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2007 American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
Correlation between VEGF serum levels on day +15 and a, maximal total serum bilirubin and b, number of days with total serum bilirubin ≥ 2 mg/dL within the first 20 days following allogeneic hematopoietic SCT.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2007 American Society for Blood and Marrow Transplantation Terms and Conditions

4. Figure 3
Overall survival of patients with high versus low VEGF serum levels on day +15 following allogeneic hematopoietic SCT. The median value of VEGF (151 pg/mL) on day +15 was used to discriminate between patients with high and low VEGF levels.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2007 American Society for Blood and Marrow Transplantation Terms and Conditions